1. Role: Others. Scope: College. Date: 2020.
Katherine S. O'Neal, Pharm.D., MBA, BCACP, CDES, BC-ADM, AE-C, CLS, FADCES
Summary
Specialties: Internal medicine, Ambulatory care/diabetes
Clinical Practice: Diabetes, hypertension, dyslipidemia, asthma, migraine
Professor; Sam K. Viersen Family Foundation Presidential Professor; PGY2 Ambulatory Care Residency Program Director; Ambulatory Care Degree Tract Option Director
Certifications & Licenses
Board Certified Ambulatory Care Pharmacist
Board of Pharmaceutical Specialties
2012Board Certified Advanced Diabetes Management
2012Certified Asthma Educator
2012Publications & Presentations
- 6. O'Neal K. Disparities in diabetes medications. 2023
7. Nguyen A, Jones E, O'Neal K, Netter M, Dwyer K. An academic-community engagement: A roadmap for developing a culturally relevant diabetes self-management program among Vietnamese Americans. . Collaborations: A Journal of Community-Based Research and Practice. 2022; 5
8. O'Neal K. Biosimilars: What have we Learned. 2022
9. Crosby K, O'Neal K. It's Hot Out There..Drug-induced photosensitivity. 2022
10. O'Neal K, Oliphant E, Johnson E, Hines M, Smith M. Prescriber and Employee Perspectives of a Health Sciences Center Campus Outpatient Pharmacy: A Qualitative Analysis. 2022
Grants
- 6. Evaluation of Merck’s Headache School: A Quasi-Experimental Examination of Effectiveness. Misc Non-Federal. Start Date: 2010. End Date: 2013.
Awards and Honors
- 26. College of Pharmacy. Educator of the Year Nominee. Date: 2014.
27. OU College of Pharmacy. Outstanding Clinical Preceptor of the Year 2012-2013. Date: 2013.
Education
- 1. Degree: PharmD. University of Oklahoma College of Pharmacy. Date: 2008.
2. Degree: MBA. University of Tulsa. Date: 2004.
Administrative Assignments
2. Role: Others. Scope: College. Date: 2020.
3. Role: Director. Scope: College. Description: PGY2 Ambulatory Care Residency Program Director. Date: 2015.
4. Role: Director. Description: Director for Ambulatory Care Track. Date: 2013.
5. Role: Others. Scope: University. Date: 2024.